Find CMO/CDMOs that produce: Biologics
Gene and cell therapy products

Gene and cell therapy products
Category
Start new search

Filters

Reset current filters

Selected filters:

Production region
Production scale
Qualifications

Located in:

United States

CDMO-CMO


Gene and cell therapy products production

Plants in:

United States

Established in: 2002

Production scale:

large

Specialized in biologics CDMO services with a focus on monoclonal antibodies.

Advanced facilities for clinical and commercial-scale manufacturing.

Strong commitment to quality and regulatory compliance.

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

  • fda

Replies slower than most

Located in:

United States

CDMO-CMO


Gene and cell therapy products production

Plants in:

United States

Established in: 2020

Production scale:

medium

Specialized in gene therapy and viral vector production.

Expertise in both clinical and commercial scale manufacturing.

Focus on quality, safety, and regulatory excellence in biologics.

  • GMP

  • FDA

  • EMA

All certificates

  • gmp

Replies slower than most

Located in:

United States

CDMO-CMO


Gene and cell therapy products production

Plants in:

United States

Established in: 2020

Production scale:

medium

Innovative approach to biomanufacturing and complex biologics.

Cutting-edge technology for next-generation therapies.

Strong focus on accelerating the development of transformative medicines.

  • GMP

  • FDA

  • EMA

All certificates

    Replies slower than most

    Located in:

    United States

    CDMO-CMO


    Gene and cell therapy products production

    Plants in:

    United States

    Established in: 1933

    Production scale:

    large

    Pioneering in advanced delivery technologies and development solutions.

    Extensive global network ensuring supply chain resilience.

    Tailored services across biologics, gene therapies, and pharmaceuticals.

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies slower than most

    Located in:

    United States

    CDMO-CMO


    Gene and cell therapy products production

    Plants in:

    United States

    Production scale:

    large

    Expertise in cell therapy development and manufacturing.

    Tailored solutions for autologous and allogeneic cell therapies.

    Cutting-edge technology for scalable and efficient cell therapy production.

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    Replies slower than most

    CDMO-CMO


    Gene and cell therapy products production

    Plants in:

    India

    Established in: 1998

    Production scale:

    small

    medium

    large

    Employees: 1000

    Facilities with global regulatory compliance

    Customized and Flexible Collaboration Models

    End-to-end drug discovery

    • GMP

    • FDA

    • EMA

    All certificates

    • gmp

    • fda

    • ema

    Replies quickly

    Looking for CMO/CDMO Services?

    Find a list of providers specializing in CMOs/CDMOs Services for Gene and cell therapy products. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.

    Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.

    CMO/CDMO - Contract (Development) Manufacturing Organizations

    CDMOs and CMOs are pivotal in the pharmaceutical and biotech industries, offering specialized services in drug development and manufacturing. They assist in scaling up production from laboratory to commercial quantities, while adhering to strict regulatory standards. These organizations play a crucial role in the efficient and cost-effective production of medical and pharmaceutical products, ensuring quality and compliance at every stage.

    Biologics

    Biologics CMOs/CDMOs specialize in the manufacturing and development of biopharmaceutical products, which are typically derived from living organisms or biological sources such as proteins, antibodies, vaccines, and cell therapies.

    Gene and cell therapy products

    Gene and cell therapy products are at the forefront of personalized medicine, treating genetic and acquired diseases. Their production involves advanced techniques to modify genes or cells, requiring stringent safety and efficacy standards, revolutionizing treatment paradigms.


    At Pharmaoffer, we feature Contract Development and Manufacturing Organizations (CDMOs) that are pioneers in the field of gene and cell therapy products. These innovative therapies represent a significant advancement in personalized medicine, offering targeted treatments for genetic and acquired diseases. This includes expertise in Gene and Cell Therapy Drug Manufacturing and Gene and Cell Therapy Production.


    Key Services Provided by Our Listed CDMOs:


    • Advanced Gene and Cell Modification: Utilization of state-of-the-art techniques for precise gene editing and cell modification to develop effective therapies. This is a key service of cell therapy CDMO and CGT CDMO providers.

    • Rigorous Safety and Efficacy Standards: Strict adherence to safety and efficacy standards, ensuring the highest level of patient safety and therapeutic effectiveness. This is crucial in cell therapy CMO services.

    • Scalable Manufacturing Solutions: Capability to scale from research-level batches to commercial-scale production, catering to the growing demand for gene and cell therapies.

    • Regulatory Expertise: In-depth understanding of the regulatory landscape governing gene and cell therapy products, ensuring compliance with FDA, EMA, and other regulatory bodies.

    • Comprehensive Development Services: From concept to commercialization, providing end-to-end development services including process development, clinical trial material production, and commercial manufacturing.


    Your Partner in Revolutionary Treatments

    Pharmaoffer connects you with CDMOs that specialize in gene and cell therapy production, essential for the new era of treatment paradigms. Our platform ensures you have access to partners with the expertise and infrastructure necessary to drive forward these groundbreaking therapies.